A primary or metastatic malignant neoplasm involving the breast. The vast majority of cases are carcinomas arising from the breast parenchyma or the nipple. Malignant breast neoplasms occur more frequ...
Comprehensive, easy-to-understand information about this condition
How we create this content →Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
Connect with organizations supporting the breast cancer community
Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Feb 1, 2026
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
AI-curated news mentioning breast cancer
Updated Feb 6, 2026
A recent study explores the resistance mechanisms of trastuzumab deruxtecan in HER2-amplified versus HER2-low breast cancer. Understanding these differences could inform treatment strategies and improve patient outcomes.
The CDC is seeking public comment on a proposed data collection project aimed at evaluating support for young breast cancer survivors and those with metastatic breast cancer. This initiative aligns with the agency's goal to reduce public burden and enhance the utility of government information.
The CDC has established an Advisory Committee on Breast Cancer in Young Women, inviting 15 individuals to contribute to this federal initiative. This committee aims to address the unique challenges faced by young women diagnosed with breast cancer.
New CDC data reveals that thousands died last year due to lack of screening for colon and breast cancer, despite most people being screened. This highlights the critical need for increased awareness and access to screening programs.